DJIA 18,162.99 121.45 0.67%
NASDAQ 5,106.59 73.84 1.47%
S&P 500 2,123.48 19.28 0.92%
market minute promo

Sanofi (ADR) (NYSE: SNY)

50.69 1.40 (2.84%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SNY $50.69 2.84%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $49.76
Previous Close $49.29
Daily Range $49.71 - $50.94
52-Week Range $43.57 - $57.42
Market Cap $133.8B
P/E Ratio 26.50
Dividend (Yield) $1.61 (2.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,167,427
Average Daily Volume 1,338,378
Current FY EPS $3.17




Drug Makers

Sanofi (ADR) (SNY) Description

A global pharmaceutical group engaged in the research, development, manufacture and marketing of healthcare products. Website:

News & Commentary Rss Feed

How Will Big Pharma Fight Back Against MannKind?

Afrezza, an inhaled insulin, is officially on the market, and threatens many big industry leaders. How will big pharma fight back against the inhaled insulin threat?

Alnylam (ALNY) Begins Phase I Study on Liver Disease Drug - Analyst Blog

Novo Nordisk And Its Promising Diabetes Drugs

European ADRs Gather Momentum as Optimism Over Greek Debt Deal Soars

Stocks Hitting 52-Week Highs

Morning Market Gainers

Health Care Sector Update for 05/27/2015: RTRX, ALDX, XBIT

Amgen's Cholesterol Fighting Drug Receives EU Approval

Amgen's PCSK9 Inhibitor a Step Closer to EU Approval - Analyst Blog

Could Incoming Threats Sink MannKind Corporation?

Big Pharma suspected that MannKind's Afrezza would make its way to the market eventually. Now that its here, what does the industry have in its pipeline that could potentially slow adoption?

See More SNY News...

SNY's Top Competitors

SNY $50.69 (2.84%)
Current stock: SNY
JNJ $101.13 (0.31%)
Current stock: JNJ
GSK $44.61 (1.76%)
Current stock: GSK
AZN $68.75 (1.58%)
Current stock: AZN